| Literature DB >> 12735700 |
Ken-ichi Kimura1, Timothy D H Bugg.
Abstract
The biosynthesis of peptidoglycan is essential for all bacteria and has no counterpart in eukaryotic cells. It is one of the prime targets for antibiotic chemotherapy, especially phospho-MurNAc-pentapeptide translocase (translocase I) is a fascinating target in which there is no commercial antibiotic. In this review we will describe three nucleoside translocase I inhibitors, mureidomycin, tunicamycin and liposidomycin.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12735700 DOI: 10.1039/b202149h
Source DB: PubMed Journal: Nat Prod Rep ISSN: 0265-0568 Impact factor: 13.423